中枢神経系（CNS）治療のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Central Nervous System Therapy Market Insights, Forecast to 2028

• レポートコード：QY2207C3852 • 出版社/出版日：QYResearch / 2022年7月11日 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の中枢神経系（CNS）治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に中枢神経系（CNS）治療の世界市場のxxx％を占める「抗うつ治療」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の中枢神経系（CNS）治療の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの中枢神経系（CNS）治療市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの中枢神経系（CNS）治療市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 中枢神経系（CNS）治療のグローバル主要メーカーには、Abbvie、Alkermes、Allergan、AstraZeneca、BIAL、Bristol-myers Squibb、Eisai、Endo Pharmaceuticals、Eli Lilly and Company、Hoffmann-LA Rocheなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 中枢神経系（CNS）治療市場は、種類と用途によって区分されます。世界の中枢神経系（CNS）治療市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 抗うつ治療、抗精神病薬療法、その他の中枢神経系障害 【用途別セグメント】 病院、クリニック 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 中枢神経系（CNS）治療製品概要 - 種類別市場（抗うつ治療、抗精神病薬療法、その他の中枢神経系障害） - 用途別市場（病院、クリニック） - 調査の目的 ・エグゼクティブサマリー - 世界の中枢神経系（CNS）治療販売量予測2017-2028 - 世界の中枢神経系（CNS）治療売上予測2017-2028 - 中枢神経系（CNS）治療の地域別販売量 - 中枢神経系（CNS）治療の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別中枢神経系（CNS）治療販売量 - 主要メーカー別中枢神経系（CNS）治療売上 - 主要メーカー別中枢神経系（CNS）治療価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（抗うつ治療、抗精神病薬療法、その他の中枢神経系障害） - 中枢神経系（CNS）治療の種類別販売量 - 中枢神経系（CNS）治療の種類別売上 - 中枢神経系（CNS）治療の種類別価格 ・用途別市場規模（病院、クリニック） - 中枢神経系（CNS）治療の用途別販売量 - 中枢神経系（CNS）治療の用途別売上 - 中枢神経系（CNS）治療の用途別価格 ・北米市場 - 北米の中枢神経系（CNS）治療市場規模（種類別、用途別） - 主要国別の中枢神経系（CNS）治療市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの中枢神経系（CNS）治療市場規模（種類別、用途別） - 主要国別の中枢神経系（CNS）治療市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の中枢神経系（CNS）治療市場規模（種類別、用途別） - 主要国別の中枢神経系（CNS）治療市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の中枢神経系（CNS）治療市場規模（種類別、用途別） - 主要国別の中枢神経系（CNS）治療市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの中枢神経系（CNS）治療市場規模（種類別、用途別） - 主要国別の中枢神経系（CNS）治療市場規模（トルコ、サウジアラビア） ・企業情報 Abbvie、Alkermes、Allergan、AstraZeneca、BIAL、Bristol-myers Squibb、Eisai、Endo Pharmaceuticals、Eli Lilly and Company、Hoffmann-LA Roche ・産業チェーン及び販売チャネル分析 - 中枢神経系（CNS）治療の産業チェーン分析 - 中枢神経系（CNS）治療の原材料 - 中枢神経系（CNS）治療の生産プロセス - 中枢神経系（CNS）治療の販売及びマーケティング - 中枢神経系（CNS）治療の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 中枢神経系（CNS）治療の産業動向 - 中枢神経系（CNS）治療のマーケットドライバー - 中枢神経系（CNS）治療の課題 - 中枢神経系（CNS）治療の阻害要因 ・主な調査結果

Market Analysis and Insights: Global Central Nervous System Therapy Market
Due to the COVID-19 pandemic, the global Central Nervous System Therapy market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Antidepressant Treatment accounting for % of the Central Nervous System Therapy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Central Nervous System Therapy market size is valued at US$ million in 2021, while the US and Europe Central Nervous System Therapy are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Central Nervous System Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Central Nervous System Therapy include Abbvie, Alkermes, Allergan, AstraZeneca, BIAL, Bristol-myers Squibb, Eisai, Endo Pharmaceuticals and Eli Lilly and Company and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Central Nervous System Therapy Scope and Segment
Central Nervous System Therapy market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Central Nervous System Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Antidepressant Treatment
Antipsychotic Therapy
Other CNS Disorder
Segment by Application
Hospital
Clinic
By Company
Abbvie
Alkermes
Allergan
AstraZeneca
BIAL
Bristol-myers Squibb
Eisai
Endo Pharmaceuticals
Eli Lilly and Company
Hoffmann-LA Roche
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Central Nervous System Therapy Product Introduction
1.2 Market by Type
1.2.1 Global Central Nervous System Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Antidepressant Treatment
1.2.3 Antipsychotic Therapy
1.2.4 Other CNS Disorder
1.3 Market by Application
1.3.1 Global Central Nervous System Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Central Nervous System Therapy Sales Estimates and Forecasts 2017-2028
2.2 Global Central Nervous System Therapy Revenue Estimates and Forecasts 2017-2028
2.3 Global Central Nervous System Therapy Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Central Nervous System Therapy Sales by Region
2.4.1 Global Central Nervous System Therapy Sales by Region (2017-2022)
2.4.2 Global Sales Central Nervous System Therapy by Region (2023-2028)
2.5 Global Central Nervous System Therapy Revenue by Region
2.5.1 Global Central Nervous System Therapy Revenue by Region (2017-2022)
2.5.2 Global Central Nervous System Therapy Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Central Nervous System Therapy Sales by Manufacturers
3.1.1 Global Top Central Nervous System Therapy Manufacturers by Sales (2017-2022)
3.1.2 Global Central Nervous System Therapy Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Central Nervous System Therapy in 2021
3.2 Global Central Nervous System Therapy Revenue by Manufacturers
3.2.1 Global Central Nervous System Therapy Revenue by Manufacturers (2017-2022)
3.2.2 Global Central Nervous System Therapy Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Central Nervous System Therapy Revenue in 2021
3.3 Global Central Nervous System Therapy Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Central Nervous System Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Central Nervous System Therapy Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Central Nervous System Therapy Sales by Type
4.1.1 Global Central Nervous System Therapy Historical Sales by Type (2017-2022)
4.1.2 Global Central Nervous System Therapy Forecasted Sales by Type (2023-2028)
4.1.3 Global Central Nervous System Therapy Sales Market Share by Type (2017-2028)
4.2 Global Central Nervous System Therapy Revenue by Type
4.2.1 Global Central Nervous System Therapy Historical Revenue by Type (2017-2022)
4.2.2 Global Central Nervous System Therapy Forecasted Revenue by Type (2023-2028)
4.2.3 Global Central Nervous System Therapy Revenue Market Share by Type (2017-2028)
4.3 Global Central Nervous System Therapy Price by Type
4.3.1 Global Central Nervous System Therapy Price by Type (2017-2022)
4.3.2 Global Central Nervous System Therapy Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Central Nervous System Therapy Sales by Application
5.1.1 Global Central Nervous System Therapy Historical Sales by Application (2017-2022)
5.1.2 Global Central Nervous System Therapy Forecasted Sales by Application (2023-2028)
5.1.3 Global Central Nervous System Therapy Sales Market Share by Application (2017-2028)
5.2 Global Central Nervous System Therapy Revenue by Application
5.2.1 Global Central Nervous System Therapy Historical Revenue by Application (2017-2022)
5.2.2 Global Central Nervous System Therapy Forecasted Revenue by Application (2023-2028)
5.2.3 Global Central Nervous System Therapy Revenue Market Share by Application (2017-2028)
5.3 Global Central Nervous System Therapy Price by Application
5.3.1 Global Central Nervous System Therapy Price by Application (2017-2022)
5.3.2 Global Central Nervous System Therapy Price Forecast by Application (2023-2028)
6 North America
6.1 North America Central Nervous System Therapy Market Size by Type
6.1.1 North America Central Nervous System Therapy Sales by Type (2017-2028)
6.1.2 North America Central Nervous System Therapy Revenue by Type (2017-2028)
6.2 North America Central Nervous System Therapy Market Size by Application
6.2.1 North America Central Nervous System Therapy Sales by Application (2017-2028)
6.2.2 North America Central Nervous System Therapy Revenue by Application (2017-2028)
6.3 North America Central Nervous System Therapy Market Size by Country
6.3.1 North America Central Nervous System Therapy Sales by Country (2017-2028)
6.3.2 North America Central Nervous System Therapy Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Central Nervous System Therapy Market Size by Type
7.1.1 Europe Central Nervous System Therapy Sales by Type (2017-2028)
7.1.2 Europe Central Nervous System Therapy Revenue by Type (2017-2028)
7.2 Europe Central Nervous System Therapy Market Size by Application
7.2.1 Europe Central Nervous System Therapy Sales by Application (2017-2028)
7.2.2 Europe Central Nervous System Therapy Revenue by Application (2017-2028)
7.3 Europe Central Nervous System Therapy Market Size by Country
7.3.1 Europe Central Nervous System Therapy Sales by Country (2017-2028)
7.3.2 Europe Central Nervous System Therapy Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Central Nervous System Therapy Market Size by Type
8.1.1 Asia Pacific Central Nervous System Therapy Sales by Type (2017-2028)
8.1.2 Asia Pacific Central Nervous System Therapy Revenue by Type (2017-2028)
8.2 Asia Pacific Central Nervous System Therapy Market Size by Application
8.2.1 Asia Pacific Central Nervous System Therapy Sales by Application (2017-2028)
8.2.2 Asia Pacific Central Nervous System Therapy Revenue by Application (2017-2028)
8.3 Asia Pacific Central Nervous System Therapy Market Size by Region
8.3.1 Asia Pacific Central Nervous System Therapy Sales by Region (2017-2028)
8.3.2 Asia Pacific Central Nervous System Therapy Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Central Nervous System Therapy Market Size by Type
9.1.1 Latin America Central Nervous System Therapy Sales by Type (2017-2028)
9.1.2 Latin America Central Nervous System Therapy Revenue by Type (2017-2028)
9.2 Latin America Central Nervous System Therapy Market Size by Application
9.2.1 Latin America Central Nervous System Therapy Sales by Application (2017-2028)
9.2.2 Latin America Central Nervous System Therapy Revenue by Application (2017-2028)
9.3 Latin America Central Nervous System Therapy Market Size by Country
9.3.1 Latin America Central Nervous System Therapy Sales by Country (2017-2028)
9.3.2 Latin America Central Nervous System Therapy Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Central Nervous System Therapy Market Size by Type
10.1.1 Middle East and Africa Central Nervous System Therapy Sales by Type (2017-2028)
10.1.2 Middle East and Africa Central Nervous System Therapy Revenue by Type (2017-2028)
10.2 Middle East and Africa Central Nervous System Therapy Market Size by Application
10.2.1 Middle East and Africa Central Nervous System Therapy Sales by Application (2017-2028)
10.2.2 Middle East and Africa Central Nervous System Therapy Revenue by Application (2017-2028)
10.3 Middle East and Africa Central Nervous System Therapy Market Size by Country
10.3.1 Middle East and Africa Central Nervous System Therapy Sales by Country (2017-2028)
10.3.2 Middle East and Africa Central Nervous System Therapy Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Abbvie
11.1.1 Abbvie Corporation Information
11.1.2 Abbvie Overview
11.1.3 Abbvie Central Nervous System Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Abbvie Central Nervous System Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Abbvie Recent Developments
11.2 Alkermes
11.2.1 Alkermes Corporation Information
11.2.2 Alkermes Overview
11.2.3 Alkermes Central Nervous System Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Alkermes Central Nervous System Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Alkermes Recent Developments
11.3 Allergan
11.3.1 Allergan Corporation Information
11.3.2 Allergan Overview
11.3.3 Allergan Central Nervous System Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Allergan Central Nervous System Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Allergan Recent Developments
11.4 AstraZeneca
11.4.1 AstraZeneca Corporation Information
11.4.2 AstraZeneca Overview
11.4.3 AstraZeneca Central Nervous System Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 AstraZeneca Central Nervous System Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 AstraZeneca Recent Developments
11.5 BIAL
11.5.1 BIAL Corporation Information
11.5.2 BIAL Overview
11.5.3 BIAL Central Nervous System Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 BIAL Central Nervous System Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 BIAL Recent Developments
11.6 Bristol-myers Squibb
11.6.1 Bristol-myers Squibb Corporation Information
11.6.2 Bristol-myers Squibb Overview
11.6.3 Bristol-myers Squibb Central Nervous System Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Bristol-myers Squibb Central Nervous System Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bristol-myers Squibb Recent Developments
11.7 Eisai
11.7.1 Eisai Corporation Information
11.7.2 Eisai Overview
11.7.3 Eisai Central Nervous System Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Eisai Central Nervous System Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Eisai Recent Developments
11.8 Endo Pharmaceuticals
11.8.1 Endo Pharmaceuticals Corporation Information
11.8.2 Endo Pharmaceuticals Overview
11.8.3 Endo Pharmaceuticals Central Nervous System Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Endo Pharmaceuticals Central Nervous System Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Endo Pharmaceuticals Recent Developments
11.9 Eli Lilly and Company
11.9.1 Eli Lilly and Company Corporation Information
11.9.2 Eli Lilly and Company Overview
11.9.3 Eli Lilly and Company Central Nervous System Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Eli Lilly and Company Central Nervous System Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Eli Lilly and Company Recent Developments
11.10 Hoffmann-LA Roche
11.10.1 Hoffmann-LA Roche Corporation Information
11.10.2 Hoffmann-LA Roche Overview
11.10.3 Hoffmann-LA Roche Central Nervous System Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Hoffmann-LA Roche Central Nervous System Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Hoffmann-LA Roche Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Central Nervous System Therapy Industry Chain Analysis
12.2 Central Nervous System Therapy Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Central Nervous System Therapy Production Mode & Process
12.4 Central Nervous System Therapy Sales and Marketing
12.4.1 Central Nervous System Therapy Sales Channels
12.4.2 Central Nervous System Therapy Distributors
12.5 Central Nervous System Therapy Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Central Nervous System Therapy Industry Trends
13.2 Central Nervous System Therapy Market Drivers
13.3 Central Nervous System Therapy Market Challenges
13.4 Central Nervous System Therapy Market Restraints
14 Key Findings in The Global Central Nervous System Therapy Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Central Nervous System Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Antidepressant Treatment
Table 3. Major Manufacturers of Antipsychotic Therapy
Table 4. Major Manufacturers of Other CNS Disorder
Table 5. Global Central Nervous System Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Central Nervous System Therapy Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Central Nervous System Therapy Sales by Region (2017-2022) & (K Units)
Table 8. Global Central Nervous System Therapy Sales Market Share by Region (2017-2022)
Table 9. Global Central Nervous System Therapy Sales by Region (2023-2028) & (K Units)
Table 10. Global Central Nervous System Therapy Sales Market Share by Region (2023-2028)
Table 11. Global Central Nervous System Therapy Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Central Nervous System Therapy Revenue Market Share by Region (2017-2022)
Table 13. Global Central Nervous System Therapy Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Central Nervous System Therapy Revenue Market Share by Region (2023-2028)
Table 15. Global Central Nervous System Therapy Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Central Nervous System Therapy Sales Share by Manufacturers (2017-2022)
Table 17. Global Central Nervous System Therapy Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Central Nervous System Therapy Revenue Share by Manufacturers (2017-2022)
Table 19. Central Nervous System Therapy Price by Manufacturers (2017-2022) &(US$/Unit)
Table 20. Global Central Nervous System Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Central Nervous System Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System Therapy as of 2021)
Table 22. Central Nervous System Therapy Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Central Nervous System Therapy Product Offered
Table 24. Date of Manufacturers Enter into Central Nervous System Therapy Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Central Nervous System Therapy Sales by Type (2017-2022) & (K Units)
Table 27. Global Central Nervous System Therapy Sales by Type (2023-2028) & (K Units)
Table 28. Global Central Nervous System Therapy Sales Share by Type (2017-2022)
Table 29. Global Central Nervous System Therapy Sales Share by Type (2023-2028)
Table 30. Global Central Nervous System Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Central Nervous System Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Central Nervous System Therapy Revenue Share by Type (2017-2022)
Table 33. Global Central Nervous System Therapy Revenue Share by Type (2023-2028)
Table 34. Central Nervous System Therapy Price by Type (2017-2022) & (US$/Unit)
Table 35. Global Central Nervous System Therapy Price Forecast by Type (2023-2028) & (US$/Unit)
Table 36. Global Central Nervous System Therapy Sales by Application (2017-2022) & (K Units)
Table 37. Global Central Nervous System Therapy Sales by Application (2023-2028) & (K Units)
Table 38. Global Central Nervous System Therapy Sales Share by Application (2017-2022)
Table 39. Global Central Nervous System Therapy Sales Share by Application (2023-2028)
Table 40. Global Central Nervous System Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Central Nervous System Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Central Nervous System Therapy Revenue Share by Application (2017-2022)
Table 43. Global Central Nervous System Therapy Revenue Share by Application (2023-2028)
Table 44. Central Nervous System Therapy Price by Application (2017-2022) & (US$/Unit)
Table 45. Global Central Nervous System Therapy Price Forecast by Application (2023-2028) & (US$/Unit)
Table 46. North America Central Nervous System Therapy Sales by Type (2017-2022) & (K Units)
Table 47. North America Central Nervous System Therapy Sales by Type (2023-2028) & (K Units)
Table 48. North America Central Nervous System Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Central Nervous System Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Central Nervous System Therapy Sales by Application (2017-2022) & (K Units)
Table 51. North America Central Nervous System Therapy Sales by Application (2023-2028) & (K Units)
Table 52. North America Central Nervous System Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Central Nervous System Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Central Nervous System Therapy Sales by Country (2017-2022) & (K Units)
Table 55. North America Central Nervous System Therapy Sales by Country (2023-2028) & (K Units)
Table 56. North America Central Nervous System Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Central Nervous System Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Central Nervous System Therapy Sales by Type (2017-2022) & (K Units)
Table 59. Europe Central Nervous System Therapy Sales by Type (2023-2028) & (K Units)
Table 60. Europe Central Nervous System Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Central Nervous System Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Central Nervous System Therapy Sales by Application (2017-2022) & (K Units)
Table 63. Europe Central Nervous System Therapy Sales by Application (2023-2028) & (K Units)
Table 64. Europe Central Nervous System Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Central Nervous System Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Central Nervous System Therapy Sales by Country (2017-2022) & (K Units)
Table 67. Europe Central Nervous System Therapy Sales by Country (2023-2028) & (K Units)
Table 68. Europe Central Nervous System Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Central Nervous System Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Central Nervous System Therapy Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Central Nervous System Therapy Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Central Nervous System Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Central Nervous System Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Central Nervous System Therapy Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific Central Nervous System Therapy Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific Central Nervous System Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Central Nervous System Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Central Nervous System Therapy Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Central Nervous System Therapy Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Central Nervous System Therapy Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Central Nervous System Therapy Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Central Nervous System Therapy Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Central Nervous System Therapy Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Central Nervous System Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Central Nervous System Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Central Nervous System Therapy Sales by Application (2017-2022) & (K Units)
Table 87. Latin America Central Nervous System Therapy Sales by Application (2023-2028) & (K Units)
Table 88. Latin America Central Nervous System Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Central Nervous System Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Central Nervous System Therapy Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Central Nervous System Therapy Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Central Nervous System Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Central Nervous System Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Central Nervous System Therapy Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Central Nervous System Therapy Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Central Nervous System Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Central Nervous System Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Central Nervous System Therapy Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa Central Nervous System Therapy Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa Central Nervous System Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Central Nervous System Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Central Nervous System Therapy Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Central Nervous System Therapy Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Central Nervous System Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Central Nervous System Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 106. Abbvie Corporation Information
Table 107. Abbvie Description and Major Businesses
Table 108. Abbvie Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 109. Abbvie Central Nervous System Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Abbvie Recent Developments
Table 111. Alkermes Corporation Information
Table 112. Alkermes Description and Major Businesses
Table 113. Alkermes Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 114. Alkermes Central Nervous System Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Alkermes Recent Developments
Table 116. Allergan Corporation Information
Table 117. Allergan Description and Major Businesses
Table 118. Allergan Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 119. Allergan Central Nervous System Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Allergan Recent Developments
Table 121. AstraZeneca Corporation Information
Table 122. AstraZeneca Description and Major Businesses
Table 123. AstraZeneca Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 124. AstraZeneca Central Nervous System Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. AstraZeneca Recent Developments
Table 126. BIAL Corporation Information
Table 127. BIAL Description and Major Businesses
Table 128. BIAL Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 129. BIAL Central Nervous System Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. BIAL Recent Developments
Table 131. Bristol-myers Squibb Corporation Information
Table 132. Bristol-myers Squibb Description and Major Businesses
Table 133. Bristol-myers Squibb Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 134. Bristol-myers Squibb Central Nervous System Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Bristol-myers Squibb Recent Developments
Table 136. Eisai Corporation Information
Table 137. Eisai Description and Major Businesses
Table 138. Eisai Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 139. Eisai Central Nervous System Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Eisai Recent Developments
Table 141. Endo Pharmaceuticals Corporation Information
Table 142. Endo Pharmaceuticals Description and Major Businesses
Table 143. Endo Pharmaceuticals Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 144. Endo Pharmaceuticals Central Nervous System Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Endo Pharmaceuticals Recent Developments
Table 146. Eli Lilly and Company Corporation Information
Table 147. Eli Lilly and Company Description and Major Businesses
Table 148. Eli Lilly and Company Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 149. Eli Lilly and Company Central Nervous System Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Eli Lilly and Company Recent Developments
Table 151. Hoffmann-LA Roche Corporation Information
Table 152. Hoffmann-LA Roche Description and Major Businesses
Table 153. Hoffmann-LA Roche Central Nervous System Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 154. Hoffmann-LA Roche Central Nervous System Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Hoffmann-LA Roche Recent Developments
Table 156. Key Raw Materials Lists
Table 157. Raw Materials Key Suppliers Lists
Table 158. Central Nervous System Therapy Distributors List
Table 159. Central Nervous System Therapy Customers List
Table 160. Central Nervous System Therapy Market Trends
Table 161. Central Nervous System Therapy Market Drivers
Table 162. Central Nervous System Therapy Market Challenges
Table 163. Central Nervous System Therapy Market Restraints
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Central Nervous System Therapy Product Picture
Figure 3. Global Central Nervous System Therapy Market Share by Type in 2021 & 2028
Figure 3. Antidepressant Treatment Product Picture
Figure 4. Antipsychotic Therapy Product Picture
Figure 5. Other CNS Disorder Product Picture
Figure 6. Global Central Nervous System Therapy Market Share by Application in 2021 & 2028
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Central Nervous System Therapy Report Years Considered
Figure 10. Global Central Nervous System Therapy Sales 2017-2028 (K Units)
Figure 11. Global Central Nervous System Therapy Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Central Nervous System Therapy Revenue 2017-2028 (US$ Million)
Figure 13. Global Central Nervous System Therapy Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Central Nervous System Therapy Sales Market Share by Region (2017-2022)
Figure 15. Global Central Nervous System Therapy Sales Market Share by Region (2023-2028)
Figure 16. North America Central Nervous System Therapy Sales YoY (2017-2028) & (K Units)
Figure 17. North America Central Nervous System Therapy Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Central Nervous System Therapy Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Central Nervous System Therapy Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Central Nervous System Therapy Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Central Nervous System Therapy Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Central Nervous System Therapy Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Central Nervous System Therapy Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Central Nervous System Therapy Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Central Nervous System Therapy Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Central Nervous System Therapy Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Central Nervous System Therapy in the World: Market Share by Central Nervous System Therapy Revenue in 2021
Figure 28. Global Central Nervous System Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Central Nervous System Therapy Sales Market Share by Type (2017-2028)
Figure 30. Global Central Nervous System Therapy Revenue Market Share by Type (2017-2028)
Figure 31. Global Central Nervous System Therapy Sales Market Share by Application (2017-2028)
Figure 32. Global Central Nervous System Therapy Revenue Market Share by Application (2017-2028)
Figure 33. North America Central Nervous System Therapy Sales Market Share by Type (2017-2028)
Figure 34. North America Central Nervous System Therapy Revenue Market Share by Type (2017-2028)
Figure 35. North America Central Nervous System Therapy Sales Market Share by Application (2017-2028)
Figure 36. North America Central Nervous System Therapy Revenue Market Share by Application (2017-2028)
Figure 37. North America Central Nervous System Therapy Sales Share by Country (2017-2028)
Figure 38. North America Central Nervous System Therapy Revenue Share by Country (2017-2028)
Figure 39. United States Central Nervous System Therapy Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Central Nervous System Therapy Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Central Nervous System Therapy Sales Market Share by Type (2017-2028)
Figure 42. Europe Central Nervous System Therapy Revenue Market Share by Type (2017-2028)
Figure 43. Europe Central Nervous System Therapy Sales Market Share by Application (2017-2028)
Figure 44. Europe Central Nervous System Therapy Revenue Market Share by Application (2017-2028)
Figure 45. Europe Central Nervous System Therapy Sales Share by Country (2017-2028)
Figure 46. Europe Central Nervous System Therapy Revenue Share by Country (2017-2028)
Figure 47. Germany Central Nervous System Therapy Revenue (2017-2028) & (US$ Million)
Figure 48. France Central Nervous System Therapy Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Central Nervous System Therapy Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Central Nervous System Therapy Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Central Nervous System Therapy Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Central Nervous System Therapy Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Central Nervous System Therapy Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Central Nervous System Therapy Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Central Nervous System Therapy Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Central Nervous System Therapy Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Central Nervous System Therapy Revenue Share by Region (2017-2028)
Figure 58. China Central Nervous System Therapy Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Central Nervous System Therapy Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Central Nervous System Therapy Revenue (2017-2028) & (US$ Million)
Figure 61. India Central Nervous System Therapy Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Central Nervous System Therapy Revenue (2017-2028) & (US$ Million)
Figure 63. China Taiwan Central Nervous System Therapy Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Central Nervous System Therapy Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Central Nervous System Therapy Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Central Nervous System Therapy Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Central Nervous System Therapy Sales Market Share by Type (2017-2028)
Figure 68. Latin America Central Nervous System Therapy Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Central Nervous System Therapy Sales Market Share by Application (2017-2028)
Figure 70. Latin America Central Nervous System Therapy Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Central Nervous System Therapy Sales Share by Country (2017-2028)
Figure 72. Latin America Central Nervous System Therapy Revenue Share by Country (2017-2028)
Figure 73. Mexico Central Nervous System Therapy Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Central Nervous System Therapy Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Central Nervous System Therapy Revenue (2017-2028) & (US$ Million)
Figure 76. Colombia Central Nervous System Therapy Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Central Nervous System Therapy Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Central Nervous System Therapy Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Central Nervous System Therapy Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Central Nervous System Therapy Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Central Nervous System Therapy Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Central Nervous System Therapy Revenue Share by Country (2017-2028)
Figure 83. Turkey Central Nervous System Therapy Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Central Nervous System Therapy Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Central Nervous System Therapy Revenue (2017-2028) & (US$ Million)
Figure 86. Central Nervous System Therapy Value Chain
Figure 87. Central Nervous System Therapy Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

---